imirestat has been researched along with ascorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eaton, JW; Hunt, JV; Jiang, ZY; Koppenol, WH; Wolff, SP; Zhou, QL | 1 |
| Nourooz-Zadeh, J; Ou, P; Tritschler, HJ; Wolff, S | 1 |
2 other study(ies) available for imirestat and ascorbic acid
| Article | Year |
|---|---|
Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro.
Topics: Aldehyde Reductase; Antioxidants; Ascorbic Acid; Copper; Diabetes Mellitus; Dose-Response Relationship, Drug; Fluorenes; Humans; Hydantoins; Imidazoles; Imidazolidines; Iron; Oxidation-Reduction; Structure-Activity Relationship | 1991 |
Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
Topics: 1-Octanol; Aldehyde Reductase; Animals; Ascorbic Acid; Chelating Agents; Copper; Enzyme Activation; Enzyme Inhibitors; Erythrocytes; Fluorenes; Glucose; Humans; Hydantoins; Hydrogen Peroxide; Hyperglycemia; Imidazoles; Imidazolidines; In Vitro Techniques; Ions; Lens, Crystalline; Lipid Peroxidation; NADP; Octanols; Oxidation-Reduction; Phenanthrolines; Rats; Thioctic Acid | 1996 |